Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers

Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers

US Patent 8007995 · Granted Aug 30, 2011

Estimated economic value: $197,210,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CDK inhibitors and uses thereof2025
ERK inhibitors and uses thereof2025
Dosage of claudin-6 conjugates for cancer treatment2025
CLAUDIN18 antibodies and methods of treating cancer2025
Claudin-6 antibodies and drug conjugates2024
Claudin18 antibodies and methods of treating cancer2023
Biomarkers and methods for determining sensitivity to epidermal growth factor re2012
Compositions and methods for the identification, assessment, prevention and ther2011
Methods for determining sensitivity to microtubule-stabilizing agents comprising2011
Compositions and methods for the identification, assessment, prevention and ther2011
Amplified and overexpressed gene in colorectal cancers2009
Amplified and overexpressed gene in colorectal cancers2009